With a degree in veterinary science and pharmacy from the UAB and a Master in Project Management from La Salle-Ramon Llull University, Carlos Lurigados has worked in drug development and licensed the results to other companies or registered them in various countries. After his time as Head of Entrepreneurship at Biocat, where he promoted the creation of new start-ups, he founded FreeOx Biotech in March 2017.
Co-founder, CEO and member of the Board of Directors at Vedanta Biosciences
Bernat Ollé holds a degree in Chemical Engineering from Rovira i Virgili University and is now living in Boston, where he did a PhD in bioprocesses at MIT. He went on to work at a venture capital and start-up group (PureTech), where he helped found companies like Follica Biosciences and Vedanta Biosciences, which he has led full-time since 2015. In 2013, he was named best young innovator in Spain by the MIT Technology journal and in 2015 he won the Princess of Girona Foundation award in Business.
Founder and Chief Scientific Officer (CSO) of Leukos Biotech
Born in Cádiz, she studied Biology in Madrid (Autonomous University of Madrid) and did her PhD thesis in immunology at the CBMSO-UAM. After that, she did a post-doc fellowship in Canada focusing on stem cells (Dr. Bhatia’s lab at the McMaster Stem Cell and Cancer Research Institute). Since 2012, she has headed up the Leukemia Stem Cells research group at the Josep Carreras Leukemia Research Institute.
Jordi Cusidó is an industrial engineer and has a PhD in Electronics from the UPC (extraordinary PhD award in ICT for his thesis). He was a project manager at a technology center for eight years and did a postgraduate degree in start-up development at Stanford. In 2013, he struck out as an entrepreneur and has never looked back. In three years, he has founded four companies, raised more than €2.5 million and been recognized with international awards (MIT Technology Review and Most Innovative SME in EU). Now he wants to expand business into four new countries, starting with the United States...
Dr. Laura Soucek is head of the Mouse Models of Cancer Therapies Group at the Vall d’Hebron Institute of Oncology (VHIO), an ICREA research professor and an associate professor at the Autonomous University of Barcelona. Ever since her undergraduate studies, she has focused her career on Myc inhibition. This project has been her personal dream and challenge for the past 20 years. Peptomyc won the Johnson & Johnson Start-up Slam Barcelona at BIO-Europe Spring for the best innovative project.
Paulo holds a PhD in Biomedical Engineering from the Eindhoven University of Technology, Netherlands, where he researched new technologies for cross-sectional brain imaging. In Barcelona, he became an associate researcher at the University of Barcelona, specializing in neuroimaging techniques. Then, he co-founded Mint Labs as CEO/CTO and has worked in this field over 10 years. He was named one of the Spanish Innovators under 35 by the MIT Technology Review in 2014.